Company Overview of NeuroHealing Pharmaceuticals Inc.
NeuroHealing Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops drug treatments for specialty indications based on repositioning neurologically active compounds. Its products include NH001, a dopaminergic agent to help post traumatic brain injury patients to emerge from a coma, vegetative, or minimally consciousness state; NH004, a treatment for the social debilitating condition of sialorrhea, a non-motor complaint of Parkinson's disease patients; and NH02D, an orally administered drug for on-demand treatment of premature ejaculation, a male sexual disorder affecting sexually active men. The company was incorporated in 2002 and is based in Newton, Massachusetts.
50 Undine Road
Unit No. 1
Newton, MA 02135
Founded in 2002
Key Executives for NeuroHealing Pharmaceuticals Inc.
Similar Private Companies By Industry
|1st Order Pharmaceuticals, Inc.||United States|
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|NYC2012, Inc.||United States|
|Tax Management Inc||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact NeuroHealing Pharmaceuticals Inc., please visit www.neurohealing.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.